Optimal delivery of perioperative chemotherapy: Preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma

Journal of Urology

Volumn 155, Issue 4, 1996, Pages 1241-1245

  Logothetis, Christopher ^a   Swanson, David ^a   Amato, Robert ^a   Banks, Marie ^a   Finn, Laury ^a   Ayala, Alberto ^a   Ro, Jae ^a   Babaian, Richard ^a   Dinney, Colin ^a   Ellerhorst, Julie ^a   Hall, Craig ^a   Von Eschenbach, Andrew ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

bladder; bladder neoplasms; chemotherapy

Indexed keywords

CISPLATIN; CREATININE; DOXORUBICIN; METHOTREXATE; VINBLASTINE SULFATE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9044235178     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66230-X     Document Type: Article

References (14)

1. Yagoda, A. and Olsson, C.: Neoplasms of the kidney, bladder, and prostate. In: Medical Oncology, 2nd ed. Edited by P. Calabresi and P. S. Schein. New York: McGraw-Hill Book Co., pp. 893-925, 1993.
2. Raghavan, D.: Chemotherapy for advanced bladder cancer: 'Mid-summer Night's Dream' or 'Much Ado About Nothing'? Brit. J. Cancer, 62: 337, 1990.
3. Fung, C. Y., Shipley, W. U., Young, R. H., Griffin, P. P., Convery, K. M., Kaufman, D. S., Althausen, A. F., Heney, N. M. and Prout, G. R., Jr.: Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J. Clin. Oncol., 9: 1533, 1991.
4. 4A): preliminary results of a randomized trial. J. Urol., part 2, 149: 317A, abstract 416, 1993.
5. 4a) bladder carcinoma. Proc. Amer. Soc. Clin. Oncol., 10: 166, abstract 529, 1991.
6. Logothetis, C. J., Dexeus, F. H., Finn, L., Sella, A., Amato, R. J., Ayala, A. G. and Kilbourn, R. G.: A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J. Clin. Oncol., 8: 1050, 1990.
7. Hall, M. C., Swanson, D. and Dinney, C.: Complications of radical cystectomy: a comparison in patients getting adjuvant MVAC chemotherapy before or after cystectomy. J. Urol., part 2, 153: 467A, abstract 955, 1995.
8. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Ahmed, T., Weiselberg, L. R., Geller, N., Hollander, P. S., Herr, H. W., Sogani, P. C., Morse, M. J. and Whitmore, W. F.: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of urothelium. J. Urol., 133: 403, 1985.
9. Tannock, I., Gospodarowicz, M., Connolly, J. and Jewett, M.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for the transitional cell carcinoma: the Princess Margaret Hospital experience. J. Urol., 142: 289, 1989.
10. Srougi, M. and Simon, S. D.: Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: a 5-year followup. J. Urol., 151: 593, 1994.
11. Scher, H. I., Yagoda, A., Herr, H. W., Sternberg, C. N., Bosl, G., Morse, M. J., Sogani, P. C., Watson, R. C., Dershaw, D. D., Reuter, V., Geller, N., Hollander, P. S., Vaughan, E. D., Jr., Whitmore, W. F., Jr. and Fair, W. R.: Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J. Urol., 139: 470, 1988.
12. Scher, H., Herr, H., Sternberg, C., Fair, W., Bosl, G., Morse, M., Sogani, P., Watson, R., Dershaw, D., Reuter, V., Curley, T., Vaughan, E. D., Jr., Whitmore, W. and Yagoda, A.: Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with M-VAC regimen. Brit. J. Urol., 64: 250, 1989.
13. Sternberg, C. N., Arena, M. G., Calabresi, F., De Carli, P., Platania, A., Zeuli, M., Giannarelli, D., Cancrini, A. and Pansadoro, V.: Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder. Cancer, 72: 1975, 1993.
14. Skinner, D. G.: Editorial: M-VAC chemotherapy in the management of locally advanced bladder cancer. J. Urol., 139: 570, 1988.